Insidra
INSIDRA

Trading Intelligence

MC
Michael T. Cullen
Director10% Owner

Michael T. Cullen insider trades: Panbela Therapeutics (PBLA) SEC Form 4 filings

Director, Panbela Therapeutics 16 Form 4 filings
16
Form 4 filings
last Mar 29, 2023
8
Grants and awards
filings
7
Other transactions
filings
2
Companies

Companies

Where Michael reports to the SEC

PBLA
PBLAPanbela Therapeutics
Director · last filing Mar 29, 2023
No market trades
SNBP
SNBPSun BioPharma
Exec. Chairman, Pres. & CEO · last filing Sep 1, 2020
No market trades

About Michael T. Cullen's insider trades

Michael T. Cullen is a director at Panbela Therapeutics (PBLA). Michael has not reported an open-market purchase or sale.

Their filings also include grants and awards (8 filings), other transactions (7 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PBLA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.